Examples of 'thrombolytic agents' in a sentence
Meaning of "thrombolytic agents"
Thrombolytic agents are medications or drugs that are used to dissolve blood clots or thrombi in the blood vessels. They work by activating a system in the body that breaks down the fibrin and platelets that form blood clots, thereby restoring blood flow in blocked or partially blocked blood vessels
How to use "thrombolytic agents" in a sentence
Basic
Advanced
thrombolytic agents
The standard treatment consists of thrombolytic agents.
Thrombolytic agents act to break down an existing blood clot.
Eptifibatide and thrombolytic agents.
One of the thrombolytic agents currently used in therapy is streptokinase.
A combination of two or several thrombolytic agents may be also used.
Use of thrombolytic agents for the treatment of acute ischemic stroke.
One approach is through injection of thrombolytic agents such as urokinase or streptokinase.
Thrombolytic agents lyse clots which cause the thromboembolic stroke.
Data are limited on the use of eptifibatide in patients receiving thrombolytic agents.
Heparin and thrombolytic agents were not available in primary care units.
This event has been reported for the therapeutic class of thrombolytic agents.
Thrombolytic agents now used in the lysis of occlusive blood clots are plasminogen activators.
This results in a better economy than in the case of other thrombolytic agents.
INTEGRILIN and thrombolytic agents.
The coronary thrombosis that causes the myocardial infarction can be lysed by thrombolytic agents.
See also
Examples of specific cardiovascular or thrombolytic agents include heparin, hirugen, hirulos and hirudin.
METALYSE belongs to a group of medicines called thrombolytic agents.
Examples of specific cardiovascular or thrombolytic agents include heparin, hirugen, hirulos and hirudine.
Data are limited on the use of INTEGRILIN in patients receiving thrombolytic agents.
Current commercially available thrombolytic agents are plasminogen activators, such as urokinase, streptokinase or tPA.
Results Most patients underwent reperfusion treatment with angioplasty or thrombolytic agents.
Because thrombolytic agents exacerbate bleeding, their use in hemorrhagic stroke is contra-indicated.
Reperfusion therapy can be done with clot-dissolving drugs called thrombolytic agents.
However, such thrombolytic agents generally should not be introduced into the patient 's circulation.
Implanted stents have been used to carry medicinal agents, such as thrombolytic agents.
Active complement blockers and thrombolytic agents may be administered together or sequentially, in any order.
After spontaneous return of the circulation, the use of thrombolytic agents was opted for.
Radioactively-labeled thrombolytic agents provided by the present invention are provided having a suitable amount of radioactivity.
These compositions may optionally include anticoagulants, antiplatelet agents, and thrombolytic agents.
Currently available thrombolytic agents include streptokinase, urokinase, and alteplase recombinant tissue plasminogen activator, rtPA.
These compounds may optionally include anticoagulants, antiplatelet agents, and thrombolytic agents.
The thrombolytic agents of the invention further have minimal side effects related to non-specific proteolysis.
Introduction Simple and efficient fibrin-directed thrombolytic agents are a major goal of the pharmaceutical industry.
Thrombolytic agents may have side effects . They may for example cause cerebral haemorrhages.
The term " thrombolysis " means the administration of thrombolytic agents.
Examples of thrombolytic agents include streptokinase, prourokinase, urokinase, and tissue-type plasminogen activator.
There are three main types of antithrombotics - platelet inhibitors, anticoagulants, and thrombolytic agents.
Examples of thrombolytic agents include streptokinase, urokinase, and tenecteplase, and tissue plasminogen activator.
There are three main types of antithrombotics-platelet inhibitors, anticoagulants, and thrombolytic agents.
Examples of thrombolytic agents ( a ) are tissue plasminogen activator ( t-PA ) and streptokinase.
These agents include, but are not limited to, thrombin inhibitors, antithrombogenic agents, thrombolytic agents e . g.
Preferred thrombolytic agents include streptokinase, urokinase, and tissue plasminogen activators ( t-PA ).
Exemplary second agents include anti-platelet, fibrinolytic, or thrombolytic agents in soluble crystalline form.
The thrombolytic agents were given intravenously as a 10 percent bolus and a 90 percent infusion over 1 hour.
Thus, SAK has an economic advantage, compared to other thrombolytic agents.
Thrombolytic agents were used in 167 patients, TNK in almost all of them.
You'll also be interested in:
Examples of using Thrombolytic
Show more
Thrombolytic therapy is the alternative to surgical treatment
The standard treatment consists of thrombolytic agents
The use of thrombolytic drugs is also indicated
Examples of using Agents
Show more
Your agents are not the most popular
Bill wants all agents back to base
Agents do not have any style anymore
